Article Details

Foamix Pharmaceuticals (NASDAQ:FOMX) Receives Buy Rating from HC Wainwright

Retrieved on: 2018-08-07 07:37:30

Tags for this article:

Click the tags to see associated articles and topics

Foamix Pharmaceuticals (NASDAQ:FOMX) Receives Buy Rating from HC Wainwright. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc acquired a new position in shares of Foamix Pharmaceuticals during the 1st quarter valued at about $369,000.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up